The coronavirus has wreaked havoc on the most established commercial real estate asset classes, creating short-term financial crunches and raising long-term secular concerns as remote work is tested and e-commerce rates rise. Attention is turning to life sciences real estate — or space that's used by pharmaceutical and biotech companies for research, development, and even manufacturing of new diagnostics, therapies, and vaccines describe Goodwin PropSci co-chairs Danielle Lauzon and Andy Sucoff. Read the article in Business Insider here.